Introduction: Early recurrence (ER) is a significant challenge for patients with colorectal peritoneal metastases (CRPM) following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS HIPEC). Preoperative risk stratification for ER would improve preoperative decision making.
Methods: We conducted a retrospective study examining patients who underwent CRS HIPEC for CRPM from 2000 to 2018.